Literature DB >> 1571316

Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?

P Franke1, W Maier, C Hain, T Klingler.   

Abstract

The Wisconsin Card Sorting Test (WCST) is a neuropsychological test, hypothesized to be an indicator of dorsolateral prefrontal cortex (DLPFC) functioning. The performance of schizophrenic patients in our sample (off medication) was worse than the performance of healthy controls in all variables of the WCST, including perseverative responses (PR) as well as non-perseverative responses (NPR). The rate of perseverative and non-perseverative responses was neither a function of the severity of the illness (measured by SANS/SAPS scales) nor the duration of the disease. Healthy siblings of schizophrenic probands revealed more perseverative responses than healthy controls, but did not show any difference with respect to the non-perseverative responses. This finding suggests that the difficulty to shift a cognitive set, reflected by the frequency of perseverative responses, is in favor of the WCST as a vulnerability marker for schizophrenia, whereas non-perseverative responses presumably indicate a state, but not a trait marker of the disease. However, the usefulness of this indicator may be limited by its association with age, which is worthy of being studied in closer detail.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1571316     DOI: 10.1016/0920-9964(92)90007-r

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  19 in total

1.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

Review 2.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

3.  Cortical blood flow during rest and Wisconsin Card Sorting Test performance in schizophrenia.

Authors:  Felipe Ortuño; Miguel Moreno-Iñiguez; Manuel Millán; César A Soutullo; Raphael M Bonelli
Journal:  Wien Med Wochenschr       Date:  2006-04

4.  Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia.

Authors:  Tejas S Bhojraj; Vaibhav A Diwadkar; John A Sweeney; Konasale M Prasad; Shaun M Eack; Debra M Montrose; Matcheri S Keshavan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-01-29       Impact factor: 5.067

5.  Identifying cognitive remediation change through computational modelling--effects on reinforcement learning in schizophrenia.

Authors:  Matteo Cella; Anthony J Bishara; Evelina Medin; Sarah Swan; Clare Reeder; Til Wykes
Journal:  Schizophr Bull       Date:  2013-11-09       Impact factor: 9.306

6.  Premorbid cognitive deficits in young relatives of schizophrenia patients.

Authors:  Matcheri S Keshavan; Shreedhar Kulkarni; Tejas Bhojraj; Alan Francis; Vaibhav Diwadkar; Debra M Montrose; Larry J Seidman; John Sweeney
Journal:  Front Hum Neurosci       Date:  2010-03-09       Impact factor: 3.169

7.  Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics.

Authors:  Haiyun Xu; Hong-Ju Yang; Bryan McConomy; Ronald Browning; Xin-Min Li
Journal:  Front Behav Neurosci       Date:  2010-03-18       Impact factor: 3.558

8.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

9.  Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats.

Authors:  Justin R Gregg; Nicole R Herring; Alipi V Naydenov; Ryan P Hanlin; Christine Konradi
Journal:  Schizophr Res       Date:  2009-07-01       Impact factor: 4.939

Review 10.  Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics.

Authors:  Catherine M Diaz-Asper; Daniel R Weinberger; Terry E Goldberg
Journal:  NeuroRx       Date:  2006-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.